Back to Endocrinology
Endocrinologyv2011Evidence-Based

Canadian Diabetes Risk Assessment Questionnaire (CANRISK)

CANRISK screens for undiagnosed type 2 diabetes mellitus and prediabetes in Canadian adults aged 18-74 years. It was developed by the Canadian Task Force on Preventive Health Care in partnership with the Public Health Agency of Canada and has been validated in Canada's multi-ethnic population.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
canrisk score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Canadian Diabetes Risk Assessment Questionnaire (CANRISK) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points from: age (0-15) + gender (0-6) + BMI (0-14) + waist circumference (0-6) + physical activity (0-1) + diet (0-2) + blood pressure (0-4) + blood sugar (0-14) + large baby (0-1) + family history (0-8) + ethnicity (0-11)

Clinical Pearls & Practice Notes

  • Validated in Canadian adults aged 18-74 years
  • Maximum possible score is 86 points
  • Ethnicity scoring: Choose only one score (the highest if multiple apply)
  • Large baby question applies to females only
  • For younger populations, particularly First Nations and Métis under 40, a lower cut-off of 21 points may be more sensitive
  • Waist circumference: Men (small <94cm, medium 94-102cm, large >102cm); Women (small <80cm, medium 80-88cm, large >88cm)

Evidence & Literature Citations

  1. Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. Chronic Dis Inj Can. 2011 Dec;32(1):19-31. PMID: 22153173.
  2. Public Health Agency of Canada. CANRISK: The Canadian Diabetes Risk Questionnaire User Guide for Pharmacists. Ottawa: Public Health Agency of Canada; 2011.
  3. Anand SS, Samaan Z, Middleton C, Irvine J, Desai D, Schulze KM, et al. A digital health intervention to lower cardiovascular risk: a randomized clinical trial. JAMA Cardiol. 2016 Aug 1;1(5):601-6. doi: 10.1001/jamacardio.2016.1035.

Score Interpretation Ranges

Low Risk0 – 20 pts

Low risk of type 2 diabetes

Moderate Risk21 – 32 pts

Moderate risk of type 2 diabetes

High Risk33 – 86 pts

High risk of type 2 diabetes

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.